Bristol-Myers Squibb
百时美施贵宝
elsewhere's corpus does not cover Bristol-Myers Squibb — the retrieved materials contain no chunks actually about the company, only background references where it appears incidentally in coverage of other subjects.
AI-generated — may contain errors, please verify.
Bristol-Myers SquibbCompany
百时美施贵宝
No graph yet
Mentioned in 5 articles
Coverage
Westlake Valley Intelligent Pharma: Cracking the AAV Delivery Challenge with AI, Entering the Super Track of In Vivo CAR-T — Gene Therapy's Moment in China | Gaorong Future
Chinese gene therapies have a real shot at genuine innovation — even leapfrogging the competition.
Interview with RayzeBio: Two Funding Rounds in Six Months, How the Surging "Radiopharma" Sector Is Transforming Cancer Treatment | Gaorong Ventures
Accelerating on the "fast track" of TRT therapy.
10 Facts About 1,000 Chinese Billionaires
The currents of the era, all contained within the sequence.
Inside Dalton Venture's Family of Companies | Boosting Long-Term Survival Rates with a Single Injection: How This Innovative Drug Developer Is Taking on Leukemia
CAR-T cell therapy is seen as a new hope in humanity's fight against cancer.
FreeS Report 23: Crossing the "Valley of Death": Systemic New Opportunities in Small-Molecule Drug R&D
Across every stage of preclinical drug R&D, new infrastructure, methods, and tools are emerging in China — making rapid, low-cost experimentation possible.
